Dr. Margaret Ilomuanya
Professor Pharmaceuticals & Pharmaceutical Technology Faculty of Pharmacy, University of Lagos
Dr. Margaret ILOMUANYA is an Associate Professor and Head of Department, Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy University of Lagos, Nigeria. She is a Fellow of the Pharmaceutical Society of Nigeria. Her laboratory focuses on novel drug delivery techniques, for development of HIV microbicides, contraceptive technologies, cosmeceuticals, and wound healing applications.
In 2019, she was listed among the top 100 Biomedical Engineers in Africa, by the Royal Academy of Engineering at the Global Grand Challenges Summit in the UK. Her research team funded by Royal Academy of Engineering UK developed a Low-cost pregnancy disorder diagnostic device for Sub-Saharan Africa – Pre-eclampsia Detector. This device has been piloted in 2 African countries. She successfully piloted the development of a topical herbal antiacne/antibacterial cream from benchtop to bed side though the NAIP Nigerian medicines’ development project in 2021. This product has been trademarked and is available for use commercially.
Dr ILOMUANYA is Principal Investigator, of the MED-AFRICA GMP Grant which facilitated the launching of MEDAFRICA GMP Laboratory at the Faculty of Pharmacy University of Lagos in 2024. This facility funded by Jeiven Pharmaceutical Inc. New Jersey USA, in collaboration with her laboratory team aim to pilot manufacture novel clinical trial HIV prevention technologies for women health. This 500,000 USD facility is the first GMP Laboratory domiciled within a University in West Africa and only the 3rd on the continent. She currently serves as a consultant to two US based pharmaceutical companies, where her work is pioneering pharmaceutical and engineering solutions to drug delivery systems for women’s health.
She has authored over 100 peer reviewed publications and book chapters. She is the recipient of various National; International grants and has received numerous awards both locally and internationally. She is currently being funded by the Bill and Melinda Gates foundation, as well as US based Pharma partners to develop first in line products for HIV/STI prevention and Non-hormonal contraception choices. She is a resource person for several international regulatory and Research agencies and has been very vocal in the international media on quality and access to medicines in Africa.
Margaret Ilomuanya is actively involved in public health engagement through research and community outreach programs where her voice resonates on the need for equity in healthcare as well as the need for collaboration to move the agenda of an effective and efficient prevention, prediction, detection, and response mechanism to health threats in Africa.
